This research develops a cytosensor that improves detection sensitivity of circulating tumor cells, indicating advancements in cancer diagnosis.
Circulating tumor cells (CTCs) are pivotal biomarkers for early cancer diagnosis and prognosis evaluation. However, their extremely low abundance and high heterogeneity in blood pose significant challenges for developing specific...
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: